alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Treasury

###### Internal Revenue Service

# AGENCY:

Internal Revenue Service (IRS), Treasury.

# ACTION:

Notice of meeting.

# SUMMARY:

An open meeting of the Taxpayer Advocacy Panel Toll-Free Phone Line Project Committee will be conducted. The Taxpayer Advocacy Panel is soliciting public comments, ideas, and suggestions on improving customer service at the Internal Revenue Service.

# DATES:

The meeting will be held Wednesday, November 15, 2017.

      ( print page 46611)    

# FOR FURTHER INFORMATION CONTACT:

Fred Smith at 1-888-912-1227 or 202-317-3087.

# SUPPLEMENTARY INFORMATION:

                    Notice is hereby given pursuant to Section 10(a)(2) of the Federal Advisory Committee Act, 5 U.S.C. App. (1988) that an open meeting of the Taxpayer Advocacy Panel Toll-Free Phone Line Project Committee will be held Wednesday, November 15, 2017, at 2:30 p.m. Eastern Time via teleconference. The public is invited to make oral comments or submit written statements for consideration. Due to limited conference lines, notification of intent to participate must be made with Fred Smith. For more information please contact Fred Smith at 1-888-912-1227 or 202-317-3087, or write TAP Office, 1111 Constitution Avenue NW., Room 1509, National Office, Washington, DC 20224, or contact us at the Web site:                     *http://www.improveirs.org.*

The committee will be discussing toll-free issues and public input is welcomed.

Dated: October 2, 2017.

Susan Jimerson,

Acting Director, Taxpayer Advocacy Panel.

[FR Doc. 2017-21477 Filed 10-4-17; 8:45 am]

 BILLING CODE 4830-01-P
[Federal Register Volume 82, Number 189 (Monday, October 2, 2017)]
[Notices]
[Page 45876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-21088]


-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4323-DR; Docket ID FEMA-2017-0001]


North Dakota; Amendment No. 1 to Notice of a Major Disaster 
Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of a major disaster declaration 
for the State of North Dakota (FEMA-4323-DR), dated July 12, 2017, and 
related determinations.

DATES: The change occurred on September 21, 2017.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and 
Recovery, Federal Emergency Management Agency, 500 C Street SW., 
Washington, DC 20472, (202) 646-2833.

SUPPLEMENTARY INFORMATION: The Federal Emergency Management Agency 
(FEMA) hereby gives notice that pursuant to the authority vested in the 
Administrator, under Executive Order 12148, as amended, James R. 
Stephenson, of FEMA is appointed to act as the Federal Coordinating 
Officer for this disaster.
    This action terminates the appointment of Thomas J. McCool as 
Federal Coordinating Officer for this disaster.

    The following Catalog of Federal Domestic Assistance Numbers 
(CFDA) are to be used for reporting and drawing funds: 97.030, 
Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis 
Counseling; 97.033, Disaster Legal Services; 97.034, Disaster 
Unemployment Assistance (DUA); 97.046, Fire Management Assistance 
Grant; 97.048, Disaster Housing Assistance to Individuals and 
Households In Presidentially Declared Disaster Areas; 97.049, 
Presidentially Declared Disaster Assistance--Disaster Housing 
Operations for Individuals and Households; 97.050, Presidentially 
Declared Disaster Assistance to Individuals and Households--Other 
Needs; 97.036, Disaster Grants--Public Assistance (Presidentially 
Declared Disasters); 97.039, Hazard Mitigation Grant.

Brock Long,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2017-21088 Filed 9-29-17; 8:45 am]
 BILLING CODE 9111-23-P
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3255 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 3255

To delay any presumption of death in connection with the kidnapping in 
 Iraq or Afghanistan of a retired member of the Armed Forces to ensure 
           the continued payment of the member's retired pay.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            October 25, 2011

Mr. Broun of Georgia introduced the following bill; which was referred 
                   to the Committee on Armed Services

_______________________________________________________________________

                                 A BILL

 
To delay any presumption of death in connection with the kidnapping in 
 Iraq or Afghanistan of a retired member of the Armed Forces to ensure 
           the continued payment of the member's retired pay.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``PROTECT Act'' or ``Protecting the 
Retirement of Our Troops by Ensuring Compensation is Timely Act''.

SEC. 2. PRESUMPTION OF DEATH FOR PARTICIPANTS IN SURVIVOR BENEFIT PLAN 
              IN MISSING STATUS.

    (a) Conditions on Presumption.--In the case of a participant in the 
Survivor Benefit Plan who has been determined by the Secretary of State 
to have been kidnapped in Iraq or Afghanistan on or after October 7, 
2001, the Secretary of a military department may not make a 
determination under section 1450(l) of title 10, United States Code, 
that the participant is missing, with the presumption of death, until 
the earlier of--
            (1) a period of at least 11 years expires after the date of 
        the determination of the Secretary of State; or
            (2) the date on which the participant is confirmed dead and 
        a death certificate is delivered to the next of kin of the 
        participant.
    (b) Resumption of Retired Pay; Payment of Back Pay.--In the case of 
a participant in the Survivor Benefit Plan described in subsection (a) 
who was presumed to be dead before the date of the enactment of this 
Act under section 1450(l) of title 10, United States Code, the 
Secretary of a military department concerned shall--
            (1) resume payment of any retired pay to which the 
        participant is entitled to as a retired member of the Armed 
        Forces pending satisfaction of the conditions specified in 
        subsection (a); and
            (2) pay retired pay for periods occurring before the date 
        of the enactment of this Act for which retired pay was not paid 
        because of the presumption of death.
                                 <all>
```
#### In re Franklin C. REAVES, PhD, Petitioner.

No. 10-2407.

United States Court of Appeals, Fourth Circuit.

Submitted: March 31, 2011.

Decided: April 4, 2011.

Franklin C. Reaves, Petitioner Pro Se.

Before NIEMEYER, SHEDD, and AGEE, Circuit Judges.

Petition denied by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Franklin C. Reaves petitions for a writ of mandamus seeking an order requiring the district court to comply with the Federal Rules of Civil Procedure. We con-*243elude that Reaves is not entitled to mandamus relief.

Mandamus relief is a drastic remedy and should be used only in extraordinary circumstances. *Kerr v. U.S. Dist. Court,*426 U.S. 394, 402, 96 S.Ct. 2119, 48 L.Ed.2d 725 (1976); *United States v. Moussaoui,*333 F.3d 509, 516-17 (4th Cir.2003). Further, mandamus relief is available only when the petitioner has a clear right to the relief sought. *In re First Fed. Sav. & Loan Ass’n,*860 F.2d 135, 138 (4th Cir.1988).

Reaves asserts various violations of the Federal Rules of Civil Procedure by the district court, all stemming from his belief that pretrial matters and a dispositive motion were improperly assigned to the magistrate judge. Mandamus, however, may not be used as a substitute for appeal. *In re Lockheed Martin Corp.,*503 F.3d 351, 353 (4th Cir.2007). As the review of any alleged errors by the district court may be had through the normal appellate process, the relief sought by Reaves is not available by way of mandamus.

Accordingly, although we grant leave to proceed in forma pauperis, we deny the petition for writ of mandamus. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*PETITION DENIED.*
Motion Granted; Abatement Order filed December 11, 2018 

In The

Fourteenth Court of Appeals

____________

NO. 14-18-00172-CV

____________

DR. JOEL JOSELEVITZ, Appellant

V.

CAROL ROANE, INDIVIDUALLY, AND COX MEDIA GROUP, Appellees

On Appeal from the 215th District Court

Harris County, Texas

Trial Court Cause No. 2014-66926

ABATEMENT ORDER

On December 4, 2018, appellant filed a third motion to extend time to file his 

reply brief noting that the parties were engaged in discussion to settle the issues on 

appeal. The motion is granted. Accordingly, we issue the following order.

The appeal is abated, treated as a closed case, and removed from this court’s 

active docket until March 1, 2019. The appeal will be reinstated on this court’s active 

docket at that time, or when the parties file a motion to dismiss the appeal or other 
dispositive motion. The court will also consider an appropriate motion to reinstate 

the appeal filed by any party, or the court may reinstate the appeal on its own motion.

PER CURIAM
#### In the Matter of Anastasi & Associates et al., Respondents, v Masaryk Towers Corporation, Appellant.

[859 NYS2d 167]

Judgment, Supreme Court, New York County (Charles E. Ramos, J.), entered August 3, 2007, confirming an arbitration award to petitioners in the principal amount of $214,073.02, unanimously affirmed, with costs.

The award was neither irrational nor contrary to public policy *(see Matter of Board of Educ. of Arlington Cent. School Dist. v Arlington Teachers Assn.,*78 NY2d 33, 37 [1991]). Respondent may not avoid payment for architectural services performed on its behalf by petitioners prior to the license suspension of one of the architects and without any evidence of misconduct on petitioners’ part in connection with this project. The court appropriately declined to divest this special proceeding of its summary nature by consolidating it with a preexisting plenary action *(see Lun Far Co. v Aylesbury Assoc.,*40 AD2d 794 [1972]). Concur—Tom, J.P, Friedman, Nardelli, Buckley and Renwick, JJ.
EX-10.19(d)



 Exhibit 10.19(d) 

AMENDMENT NO. 3 TO EXCLUSIVE LICENSE AGREEMENT 

THIS Amendment No. 3 to Exclusive License Agreement (“Amendment 3”) is made and entered into this 5th day of May, 2015
(“Effective Date of Amendment 3”), by and between the Mayo Foundation for Medical Education and Research (“Mayo”) having its principal place of business at 200 First Street SW, Rochester, Minnesota 55905, and Unity Biotechnology,
Inc. (formerly known as Cenexys, Inc.), a Delaware corporation, having a place of business at 1700 Owen Street, Suite 535 San Francisco, California 94158 (“Company”), for purposes of confirming the parties’ intent and agreement as set
forth herein. 
 BACKGROUND 

Mayo and Company are parties to an Exclusive License Agreement, with an effective date of the 28th day of June, 2013 (“Agreement”),
which confirms the parties’ intent and agreement to grant an exclusive license to Mayo’s certain patent rights and a nonexclusive license to certain know-how along with Amendment No. I and Amendment
No. 2 to the Agreement. Mayo and Company wish to amend the Agreement as set forth in this Amendment No. 3, and, accordingly, Mayo and Company agree as follows: 

AMENDED TERMS 
 Exhibit A in its entirety will be
deleted and replaced with the exhibit attached to this Amendment No. 3. 
 All other terms of the Agreement and Amendment No. 2
shall remain in full force and effect for the term of the Agreement and as set forth in the Agreement. 
 IN WITNESS WHEREOF, Mayo and Company hereby enter
into this Amendment No. 3, effective as of the date first set forth above. 
  

									
	Unity Biotechnology, Inc.	 		 	Mayo Foundation for Medical Education and Research
					
	By:	 	 /s/ Nathaniel E. David
	 		 	By:	 	 /s/ Daniel D. Estes

	Name:	 	Nathaniel E. David, PhD	 		 	Name:	 	Daniel D. Estes
	Title:	 	President	 	        	 	Title:	 	Assistant Treasurer


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 








 EXHIBIT A 

PATENT RIGHTS 
 [***] 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
<PAGE>   1
                                                                      Exhibit 21


Maxxim Medical Inc.
List of Subsidiaries
As of October 29, 2000

                                        State of                %
Subsidiary                            Incorporation          Ownership
----------                            -------------          ---------

Maxxim Medical Group, Inc.              Delaware               100%
Maxxim Medical Inc.                     Delaware               100%
Maxxim Investment Management Inc.       Nevada                 100%
Fabritek LaRomana, Inc.                 Mississippi            100%
Maxxim Medical FSC, Inc.                Barbados               100%
Maxxim Medical Canada, Limited          Canada                 100%
Maxxim Medical Holdings Europe, BV      Netherlands            100%
Maxxim Medical Europe B.V.              Netherlands            100%
Maxxim Medical Belgium NV               Belgium                100%
[Federal Register Volume 82, Number 189 (Monday, October 2, 2017)]
[Notices]
[Page 45871]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20992]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Nursing Research; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Nursing Research 
Initial Review Group.
    Date: October 19-20, 2017.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Weiqun Li, MD, Scientific Review Officer, 
National Institute of Nursing Research National Institutes of 
Health, 6701 Democracy Blvd., Suite 710, Bethesda, MD 20892, (301) 
594-5966, <a href="/cdn-cgi/l/email-protection#9cebf0f5dcf1fdf5f0b2f2f5f4b2fbf3ea"><span class="__cf_email__" data-cfemail="5423383d1439353d387a3a3d3c7a333b22">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.361, 
Nursing Research, National Institutes of Health, HHS)

    Dated: September 26, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-20992 Filed 9-29-17; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<PAGE>


EXHIBIT 32.1


           Section 906 of the Sarbanes-Oxley Act of 2002 Certification
                                 (filing copy)


To Whom It May Concern,

         In connection with the Annual Report of Ingen Technologies Inc.
("Ingen") on Form 10-KSB for the fiscal year ended May 31st, 2005 as filed with
the Securities and Exchange Commission on or very near the date hereof ("the
Report"), I, Scott R. Sand, Chief Executive Officer and Chairman of Ingen,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

         (1)  The Report fully complies with the requirements of Section 13(a)
              of the Securities Exchange Act of 1934, and

         (2)  The information contained in the Report fairly represents, in all
              material respects, the financial condition and results of
              operations of Ingen.

         /s/ Scott R. Sand
         ------------------------------------
         Scott R. Sand
         Chief Executive Officer and Chairman

         November 4, 2005
EX-32.1


**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the accompanying Quarterly Report on Form 10-QSB (the "Report")
      of WI-TRON, INC. (the "Company") for the quarter ended March 31, 2007, I, John
      C. Lee, Chief Executive Officer of the Company, hereby certify pursuant to
      18
      U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, to the best of my knowledge and belief, that:





(1)  The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and


(2)  The
      information contained in the Report, fairly presents, in all material respects,
      the financial condition and results of operations of the Company.





A
      signed
      original of this written statement required by Section 906 has been provided
      to
      Wi-Tron, Inc., and will be retained by Wi-Tron, Inc. and furnished to the
      Securities and Exchange Commission or its staff upon request.








/s/
                John C. Lee
            June
                19, 2007John
                C. LeeChief
                Executive Officer





19
I 

111TH CONGRESS 

1ST SESSION H. R. 2633 

To amend the Emergency Economic Stabilization Act of 2008 to prohibit 

automobile manufacturers receiving assistance under the Troubled Asset 

Relief Program from opening a new foreign subsidiary or expanding 

their current foreign subsidiaries. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 21, 2009 

Mr. ROGERS of Michigan (for himself, Mrs. MILLER of Michigan, and Mr. 

HOEKSTRA) introduced the following bill; which was referred to the Committee on Financial Services 

A BILL 

To amend the Emergency Economic Stabilization Act of 

2008 to prohibit automobile manufacturers receiving assistance under the Troubled Asset Relief Program from 

opening a new foreign subsidiary or expanding their current foreign subsidiaries. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

mstockstill@gpo.gov on PROD1PC66 with BILLS

2 

•HR 2633 IH

1 SECTION 1. PROHIBITION ON AUTOMOBILE MANUFAC2 TURER EXPANSION OF NEW OR CURRENT 

3 FOREIGN SUBSIDIARIES. 

4 (a) IN GENERAL.—Title I of the Emergency Eco5 nomic Stabilization Act of 2008 is amended by adding at 

6 the end the following new section: 

7 ‘‘SEC. 137. PROHIBITION ON AUTOMOBILE MANUFACTURER 

8 EXPANSION OF NEW OR CURRENT FOREIGN 

9 SUBSIDIARIES. 

10 ‘‘(a) IN GENERAL.—Effective as of the date of the 

11 enactment of this section, no automotive TARP recipient 

12 may open a new foreign subsidiary or expand any current 

13 foreign subsidiary. 

14 ‘‘(b) AUTOMOTIVE TARP RECIPIENT DEFINED.— 

15 For purposes of this section, the term ‘automotive TARP 

16 recipient’ means any automobile manufacturer that has 

17 received assistance under this title and that has not fully 

18 repaid such assistance.’’. 

19 (b) CONFORMING AMENDMENT.—The table of con20 tents for such Act is amended by inserting after the item 

21 relating to section 136 the following new item: 

‘‘137. Prohibition on automobile manufacturer expansion of new or current foreign subsidiaries.’’. 

Æ 

mstockstill@gpo.gov on PROD1PC66 with BILLS
IIB 

112TH CONGRESS 

1ST SESSION H. R. 313 

IN THE SENATE OF THE UNITED STATES 

DECEMBER 14, 2011 

Received; read twice and referred to the Committee on the Judiciary 

AN ACT 

To amend the Controlled Substances Act to clarify that 

persons who enter into a conspiracy within the United 

States to possess or traffic illegal controlled substances 

outside the United States, or engage in conduct within 

the United States to aid or abet drug trafficking outside 

the United States, may be criminally prosecuted in the 

United States, and for other purposes. 


tjames on DSK6SPTVN1PROD with BILLS
2 

HR 313 RFS 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Drug Trafficking Safe 

5 Harbor Elimination Act of 2011’’. 

6 SEC. 2. AMENDMENTS TO THE CONTROLLED SUBSTANCES 

7 ACT TO CLARIFY CONSPIRACIES CONDUCTED 

8 WITHIN THE UNITED STATES MAY BE CRIMI9 NALLY PROSECUTED IN THE UNITED STATES. 

10 Section 406 of the Controlled Substances Act (21 

11 U.S.C. 846) is amended by— 

12 (1) inserting ‘‘(a)’’ before ‘‘Any’’; and 

13 (2) inserting at the end the following: 

14 ‘‘(b) Whoever, within the United States, conspires 

15 with one or more persons, or aids or abets one or more 

16 persons, regardless of where such other persons are lo17 cated, to engage in conduct at any place outside the 

18 United States that would constitute a violation of this 

19 title, other than a violation of section 404(a), if committed 

20 within the United States, shall be subject to the same 


tjames on DSK6SPTVN1PROD with BILLS
3 

HR 313 RFS 

1 penalties that would apply to such conduct if it were to 

2 occur within the United States.’’. 

Passed the House of Representatives December 13, 

2011. 

Attest: KAREN L. HAAS, 

Clerk. 


tjames on DSK6SPTVN1PROD with BILLS